Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Manylion Llyfryddiaeth
Prif Awdur:	Tania, Umme
Awduron Eraill:	Khan, Tanisha
Fformat:	Traethawd Ymchwil
Iaith:	English
Cyhoeddwyd:	Brac University 2023
Pynciau:	Biologics Biosimilars Bevacizumab Non-small cell lung cancer Regulatory frameworks Targeted therapy Lungs > Cancer
Mynediad Ar-lein:	http://hdl.handle.net/10361/18736

Eitemau Tebyg

A review on targeted therapies for lung cancer
gan: Ashraf, Anushey
Cyhoeddwyd: (2023)

Molecules associated with the development of lung cancer
gan: Rahman, Adree, et al.
Cyhoeddwyd: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
gan: Paul, Pulock
Cyhoeddwyd: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
gan: Jeba, Joynob
Cyhoeddwyd: (2017)

Potential of liposomes for the treatment of lung cancer- a review
gan: Mim, Shanzida
Cyhoeddwyd: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
gan: Rahman, Tasnim
Cyhoeddwyd: (2024)

Biosimilar in lymphoma treatment
gan: Tanisha, Mehrin Haque
Cyhoeddwyd: (2021)

A review on recent advances in drugs for lung cancer treatment
gan: Noor, Fouzia
Cyhoeddwyd: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
gan: Hoque, Ismoth Ara
Cyhoeddwyd: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
gan: Razna, Amrin Islam
Cyhoeddwyd: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
gan: Bristy, Israt Zerin
Cyhoeddwyd: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
gan: Shabnam, Musharrat
Cyhoeddwyd: (2018)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
gan: Pial, Sazia Afrin
Cyhoeddwyd: (2018)

Immunotherapy in the Management of Lung Cancer
gan: Tasnim, Humayra
Cyhoeddwyd: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
gan: Zangmo, Thinley
Cyhoeddwyd: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
gan: Nandy, Aditi
Cyhoeddwyd: (2022)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Flora, Sanzida Alam
Cyhoeddwyd: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
gan: Alam, Kazi Tasnuva
Cyhoeddwyd: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
gan: Das, Reshita
Cyhoeddwyd: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
gan: Tania, Umme
Cyhoeddwyd: (2021)

Lung cancer detection and classification using machine learning
gan: Arefin, Mahbubul, et al.
Cyhoeddwyd: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
gan: Mukti, Roushney Fatima, et al.
Cyhoeddwyd: (2016)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Karim, Samia Binte
Cyhoeddwyd: (2024)

Stem cells as therapeutic carrier in cancer treatment
gan: Anika, Mysha Yeasmin
Cyhoeddwyd: (2022)

SIRT6 and cancer stem cells: is there any implication?
gan: Sarker, Tanosi
Cyhoeddwyd: (2022)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
gan: Nawar, Anika
Cyhoeddwyd: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
gan: Nahar, Kamrun
Cyhoeddwyd: (2023)

Biologics and Biosimilars as Treatment Options for Psoriasis
gan: Moya, Amena Khatun
Cyhoeddwyd: (2023)

Targeting BRAFV600E in the treatment of CRC
gan: Roja, Mashwiyat Samrin
Cyhoeddwyd: (2024)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
gan: Pecorino, Lauren
Cyhoeddwyd: (2012)

Trend in approval of targeted biologics in the last two decades
gan: Siddika, Khadiza
Cyhoeddwyd: (2024)

Dendritic cell vaccine for the treatment of cancer
gan: Haque, Tanzila
Cyhoeddwyd: (2023)

Biosimilars: A revolution for biologics in the pharmaceutical industry
gan: Moreino, Shannon Sherwin
Cyhoeddwyd: (2018)

Stem cell in cancer disease cure vs cause
gan: Chowdhury, Marisha Mansur
Cyhoeddwyd: (2023)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
gan: F. S. Amaral, André, et al.
Cyhoeddwyd: (2017)

RIPK pathway, as a potential target, for cancer treatment - a review
gan: Jahan, Nusrat
Cyhoeddwyd: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
gan: Emon, Kamrul Hasan
Cyhoeddwyd: (2022)

CAR-T cell Therapy in B-cell Lymphoma
gan: Faruk, Asef
Cyhoeddwyd: (2020)

Biosimilar insulins: a potential option in the treatment of Diabetes
gan: Tabassum, Turana
Cyhoeddwyd: (2022)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
gan: Auvy, Akib Al Mahmud, et al.
Cyhoeddwyd: (2023)